You have no items in your shopping cart.
Product Description
Executive Summary
Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, the overall survival remains below five years.
There are today 304 (268) companies plus partners developing 417 (360) drugs targeting breast cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 155 (116) drugs. Breast Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 207 (180) different targets. These targets are further categorized on the CD-ROM by 55 (52) classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath. Figures in brackets are comparative data from last year.
Find and sort drugs by twelve different parameters plus free text search field. Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser, whether it is a single drug profile or an entire search you want have a report of.
How May This Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.
Drug Pipeline Update at a Glance
| Investigators | Includes more than 304 (268) principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators. Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator. |
| Drug name & Synonyms | Lists commercial, generic and code names for drugs. |
| Developmental stage | This Drug Pipeline Update contains 417 (360) drugs in active development for the treatment of breast cancer: Marketed# 53 (53) Pre-registration# 2 Phase III# 18 (15) Phase II# 136 (129) Phase I# 83 (76) Preclinical# 95 (85) No Data# 19 (19) Suspended# 4 Discontinued# 7 In addition there are 155 (116) ceased drugs. Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application. |
| Indications | Included breast cancer drugs are also in development for 177 (140) other indications, where of 74 are different cancer indications. Note: You are able to find and sort drugs according to type of indication from drop-down menu in the application. |
| Targets | Identified drugs are linked to more than 207 (180) different targets, divided into 55 (52) classifications of molecular function: - Catalytic activity - Cell adhesion molecule activity - Chaperone activity - Chemokine activity - Complement activity - Cysteine-type peptidase activity - Cytokine activity - DNA binding - DNA repair protein - DNA topoisomerase activity - DNA-directed DNA polymerase activity - Extracellular ligand-gated ion channel activity - Extracellular matrix structural constituent - Glutathione transferase activity - G-protein coupled receptor activity - Growth factor activity - Growth factor binding - Hormone activity - Ion channel activity - Isomerase activity - Kinase activity - Kinase binding - Kinase regulator activity - Ligand-dependent nuclear receptor activity - Ligase activity - Lipid kinase activity - Lipid phosphatase activity - Metallopeptidase activity - Molecular function unknown - Motor activity - Oxidoreductase activity - Peroxidase activity - Phosphoric diester hydrolase activity - Protein binding - Protein serine/threonine kinase activity - Protein threonine/tyrosine kinase activity - Protein-tyrosine kinase activity - Receptor activity - Receptor binding - Receptor signaling complex scaffold activity - Receptor signaling protein serine/threonine kinase activity - RNA-directed DNA polymerase activity - Serine-type peptidase activity - Structural constituent of cytoskeleton - Structural molecule activity - Superoxide dismutase activity - T cell receptor activity - Transcription factor activity - Transcription regulator activity - Transferase activity - Translation regulator activity - Transmembrane receptor activity - Transmembrane receptor protein tyrosine kinase activity - Transporter activity - Voltage-gated ion channel activity Identified targets are categorized into 26 (22) different primary and alternate sub-cellular localizations: - Cell projection - Centrosome - Clathrin-coated vesicle - Cytoplasm - Cytoplasmic vesicle - Cytoskeleton - Cytosol - Endoplasmic reticulum - Endosome - Extracellular - Golgi apparatus - Integral to membrane - Lysosome - Microtubule - Mitochondrial membrane - Mitochondrion - Nuclear membrane - Nucleolus - Nucleus - Perinuclear region - Perinuclear vesicle - Peroxisome - Plasma membrane - Secreted - Secretory granule - Secretory vesicle Note: You are able to find and sort drugs according to target gene name, molecular function of target, and target localization from drop-down menus in the application. |
| Target Expression Profile | Direct links are provided from inside the application to 252 (206) protein expression profiles of 156 (133) drug targets in various human tissues and cancer types, cell lines and primary cells, including up to: - 48 different normal tissue types - 20 different types of cancer - 47 cell lines - 12 samples of primary blood cells |
| Pathway Referals | Identified targets have been cross referenced against their involvement in different cellular pathways, according to BioCarta, KEGG and NetPath. - BioCarta# 228 (224) Pathways - KEGG# 117 (82) Pathways - NetPath# 20 (20) Signaling Pathways Note: You are able to find and sort drugs according to targeted pathways from drop-down menus in the application. |
| Mechanism | In total there are 273 (215) different drug mechanism of action represented in this Drug Pipeline Update. Note: You are able to find and sort drugs according to mechanism of action from drop-down menu in the application. |
| Compound | Identified drug compounds are described by: Compound type, Chemical name, CAS Number and molecular weight Note: You are able to sort and find drugs according to compound type from drop-down menu in the application. |
| Drug Profile | Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information: Drug Name & Synonyms Presentation of drug name and synonyms Principal Investigator & Partners Presentation of principal investigator and partners Target and Molecular Function of Target Described target(s) is/are presented with: Official Gene Symbol Official Gene Name [Species/Homo Sapiens] Molecular Function Target Localization Described target(s) is/are presented with primary and alternate localizations. Target Expression Profiles Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to: 48 different normal tissue types 20 different types of cancer 47 cell lines 12 samples of primary blood cells Targeted Pathways Described target(s) is/are matched for the involvement in cellular pathways according to BioCarta, KEGG, and NetPath. Mechanism Drug mechanism of action Developmental Projects Summary field of developmental projects for the drug, including indication, developmental stage and status. Example: Cancer, myeloma Phase II Clinical Trial Active Cancer, prostate Phase III Clinical Trial Ceased Drug Description Short introduction to drug Compound Data Compound type, Chemical name, CAS Number and molecular weight Patent Data Available patent information related to the drug is presented here. Business & Markets Collaborations and deals Approvals and submissions Analyst comments Phase III Data Available Phase III development data, developmental history and scientific data. Phase II Data Available Phase II development data, developmental history and scientific data. Phase I Data Available Phase I development data, developmental history and scientific data. Preclinical Data Available preclinical development data, developmental history and scientific data. Licensing Information Availability for licensing |
| Application Features | Use 13 different parameters, available in drop-down menus, to find and sort among drugs - Drug status - Clinical Trial Status - Principle Investigator - Partners - Indication - Developmental Stage - Compound Type - Mechanism - Target - Molecular Function of Target - Target Localization - Targeted Pathways - Free text search of entire drug profile contents Direct linkage from inside the application to related internet resources - Drug data is linked to search engines like Google and PubMed - Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, and NetPath - Direct links to company web pages of principal investigators Dynamic Report Generator Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser (Internet Explorer and FireFox), whether it is a single drug profile or an entire search you want have a report of. |
| System Requirements | - AMD-Athlon/Pentium II PC - Windows 98/NT4/2000/ME/XP/VISTA/Windows 7 - 8x-speed CD Rom drive - SVGA 16 bit display. (32 bit recommended) - 32 MB of available RAM (128 MB recommended) - Browser Application (Internet Explorer, Firefox) - Internet access (to access related internet resources) |